<DOC>
	<DOCNO>NCT01299116</DOCNO>
	<brief_summary>In propose study , woman age 18-29 seek oral injectable contraception offer opportunity try LARC instead ; FDA-approved option include two type intrauterine product one type subdermal contraceptive implant . Over 24 month period , experience LARC user compare experience opt initial short-acting method .</brief_summary>
	<brief_title>Long-Acting Reversible Contraception</brief_title>
	<detailed_description>In partially randomize patient preference study , woman age 18-29 seek oral injectable contraception offer opportunity try LARC instead ; FDA-approved option include two type intrauterine product one type subdermal contraceptive implant . Over 24-month period , experience LARC user compare experience opt initial short-acting method . It expect 38 % participant use short-acting method stop use first year risk unintended pregnancy . In contrast , le 20 % LARC user want contraceptive remove . Continuation rate measure pregnancy tally two group document difference emerge .</detailed_description>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>18 29 year age ; sexually active ; seek oral injectable contraception ; work cell phone ; work email account ; willingness contact clinic staff study coordinator ; , willingness complete questionnaire . currently pregnant ; previous use longacting reversible contraceptive ( LARC ) method ; , medical contraindication oral contraceptive injectables .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>AE adverse event</keyword>
	<keyword>FDA ( U.S. ) Food Drug Administration</keyword>
	<keyword>GCP Good Clinical Practice guideline</keyword>
	<keyword>ICH International Conference Harmonisation</keyword>
	<keyword>IRB Institutional Review Board</keyword>
	<keyword>IU International unit</keyword>
	<keyword>mg milligram ( )</keyword>
	<keyword>mm3 cubic millimeter ( )</keyword>
	<keyword>LARC Long-Acting reversible contraception</keyword>
	<keyword>PPCNC Planned Parenthood North Carolina</keyword>
	<keyword>SAE serious adverse event</keyword>
	<keyword>SARC Short-Acting reversible contraception</keyword>
	<keyword>Âµg microgram</keyword>
	<keyword>ULN upper limit normal range</keyword>
</DOC>